Electronic health record and health IT software businesses are often valued differently than traditional software companies because their economics are driven by recurring revenue, implementation complexity, and customer switching friction. For Orlando business owners in healthcare technology, especially those serving providers in Lake Nona Medical City, Winter Park, and the broader Central Florida healthcare market, […]
Executive Summary. AI-powered diagnostics companies occupy a distinctive place in business valuation because their worth often depends on more than current revenue. Buyers and investors evaluate FDA clearance, clinical validation, reimbursement strategy, data quality, recurring licensing contracts, and the ability to scale across health systems. Those factors can support premium valuation multiples when the platform […]
Executive Summary: Revenue Cycle Management (RCM) companies are valued for more than software functionality. Their economics are driven by revenue per provider, claim success rates, net revenue retention, and the degree to which their platforms are embedded in day-to-day billing workflows. For buyers and investors, these metrics help determine whether an RCM software company deserves […]
Executive Summary: Valuing a telehealth platform requires more than looking at headline revenue. Buyers and investors focus on patient visit volume, revenue per visit, payer contract penetration, retention, and the extent to which post-pandemic demand has normalized. The most reliable valuations combine recurring revenue analysis, churn and cohort trends, reimbursement quality, and profitability metrics such […]
Executive Summary: Healthtech companies are valued differently than traditional businesses because investors and buyers look beyond current earnings to understand recurring revenue quality, patient engagement, clinical results, and whether the product has clear regulatory footing. For digital health firms, ARR, retention, churn, gross margin, and clinical validation often carry more weight than short-term EBITDA alone. […]
Executive Summary: InsurTech companies are often valued less like traditional insurers and more like recurring revenue businesses with underwriting risk attached. For Orlando business owners, investors, and advisors, the most important metrics are loss ratio, combined ratio, premium growth, and retention, because they reveal whether growth is profitable, durable, and scalable. Embedded insurance distribution adds […]
Executive Summary: Buy-now-pay-later, or BNPL, businesses are being valued with far more emphasis on fundamentals than on growth headlines. For Orlando business owners, investors, and advisors evaluating a BNPL company, the metrics that matter most are gross merchandise value (GMV), merchant fee rate, default rate, and the quality of unit economics. In today’s market, buyers […]
Executive summary: Neobanks, also called challenger banks, are not priced like traditional banks because their economics are different. Investors usually focus on deposits per user, customer acquisition cost (CAC), revenue per account, churn, net revenue retention, and the path to profitability rather than relying mainly on price-to-book multiples. For Orlando business owners, including founders considering […]
Executive Summary: Valuing a payment processing company requires more than applying a generic revenue multiple. Buyers and investors focus on total payment volume (TPV), take rate, gross margin, retention, and churn because those metrics reveal how durable the economics are behind each transaction. In practice, a processor that handles large volumes but earns thin margins […]
Executive Summary: Fintech companies are valued differently from traditional businesses because buyers and investors look beyond current profit and focus on growth, retention, regulatory positioning, and the quality of revenue. For financial technology companies in payments, lending, and neobanking, valuation often centers on revenue multiples, adjusted EBITDA, and scenario based discounted cash flow analysis, with […]
- 1
- 2